GO:0010465 nerve growth factor receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010465 (nerve growth factor receptor activity) is a molecular function defined as combining with nerve growth factor (NGF) to prevent apoptosis in neurons and promote nerve growth, or to initiate a change in cell activity.
• The term covers both the TrkA (NTRK1) high-affinity receptor and the p75NTR (NGFR) receptor, which together mediate the two-receptor system for NGF signaling.
• NGFR/p75NTR signaling is now recognized far beyond neurobiology, including roles in osteoarthritis joint remodeling, glioblastoma progression, melanoma lymphangiogenesis and metastasis, triple-negative breast cancer growth, type 1 diabetes brain changes, and germinal center stromal activation.
• Because the same receptor can drive opposing outcomes depending on context, researchers need precise, isogenic cell models to dissect which downstream pathway is engaged.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are the standard tools for assigning causality to NGFR/NTRK1 variants and their signaling partners.
• The term is a molecular_function node in the Gene Ontology, with synonyms beta-nerve growth factor receptor activity and NGF receptor activity.
Description
GO:0010465, nerve growth factor receptor activity, is a Gene Ontology molecular_function term describing the ability of a receptor to combine with nerve growth factor (NGF) and thereby prevent apoptosis in neurons, promote nerve growth, or initiate a change in cell activity. This activity sits at the top of one of the best-studied neurotrophin signaling systems, in which NGF engages two distinct receptors, the TrkA tyrosine kinase (encoded by NTRK1) and the p75 neurotrophin receptor (encoded by NGFR), to produce context-dependent cellular responses. The dual-receptor architecture means that a single ligand can trigger survival, differentiation, or apoptosis depending on which receptor dominates and which co-receptors are present. For researchers, GO:0010465 is therefore not a single linear pathway but a signaling hub whose output must be measured experimentally in each biological system. Interest in this term has expanded well beyond classical neurotrophic biology. NGFR signaling has been implicated in limiting inflammation and promoting remodeling and repair of osteoarthritic joints, in driving glioblastoma progression, in melanoma-derived small extracellular vesicle-induced lymphangiogenesis and metastasis, in increasing tumor growth and metastatic potential of triple-negative breast cancer cells, in streptozotocin-induced type 1 diabetes rat brain, and in regulating stromal cell activation in germinal centers. This breadth makes GO:0010465 a recurring annotation in cancer, neuroscience, immunology, and musculoskeletal research. The practical challenge for laboratories is that NGF receptor activity is highly sensitive to cell type, receptor ratio, and downstream adaptor availability. Assigning a phenotype to this activity therefore requires loss-of-function and gain-of-function perturbations that isolate the receptor from its ligand and from parallel signaling routes. This article summarizes the definition, mechanism, key genes, disease links, and the CRISPR-based research methods used to study GO:0010465.
nerve growth factor receptor activity At A Glance
| GO ID | GO:0010465 |
|---|---|
| GO term | nerve growth factor receptor activity |
| Ontology | molecular_function |
| Synonym | beta-nerve growth factor receptor activity; NGF receptor activity |
| Definition | Combining with nerve growth factor (NGF), to prevent apoptosis in neurons and promote nerve growth, or to initiate a change in cell activity. |
| Major function | NGF binding coupled to neuronal survival, neurite growth, or a change in cell activity |
| Representative receptors | TrkA (NTRK1) and p75NTR (NGFR) |
| Disease relevance | Osteoarthritis, glioblastoma, melanoma metastasis, triple-negative breast cancer, type 1 diabetes brain, germinal center biology |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, signaling assays, imaging, transcriptomics |
What Is GO:0010465?
In plain terms, GO:0010465 describes what an NGF receptor does at the molecular level: it binds nerve growth factor and, as a result, either protects neurons from apoptosis and supports nerve growth or triggers a change in cell behavior. The QuickGO definition emphasizes that the activity is defined by ligand binding coupled to a cellular outcome, not by a single enzymatic reaction. The term includes the high-affinity TrkA receptor and the p75NTR receptor, both of which bind NGF and can initiate signaling. Its synonyms, beta-nerve growth factor receptor activity and NGF receptor activity, reflect historical naming of the same binding-and-signaling function.
Why Is nerve growth factor receptor activity Important in Cell Biology?
GO:0010465 matters because NGF receptor activity is a decision point that can push a cell toward survival, growth, or death, and because the same activity has been linked to diseases as different as osteoarthritis, glioblastoma, melanoma, breast cancer, diabetes-associated brain changes, and germinal center dysfunction. Understanding which receptor, which adaptor, and which downstream pathway mediates a given phenotype is essential for interpreting disease mechanisms and for designing targeted interventions.
• Defines the molecular function that links NGF ligand binding to neuronal survival and nerve growth.
• Covers two distinct receptors, TrkA and p75NTR, whose balance determines the cellular outcome.
• NGFR signaling limits inflammation and promotes remodeling and repair in osteoarthritic joints.
• NGFR is a key player in glioblastoma progression.
• Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism.
• NGFR increases tumor growth and metastatic potential of triple-negative breast cancer cells.
• TrkA signaling is altered in the brain in streptozotocin-induced type 1 diabetes.
• NGFR regulates stromal cell activation in germinal centers, linking the term to immune regulation.
• The term is a frequent annotation in cancer, neuroscience, and musculoskeletal research, making it a high-value target for functional genomics.
Molecular Mechanism of nerve growth factor receptor activity
NGF binding and receptor engagement
In simple terms: NGF binds to its receptors on the cell surface, like a key fitting a lock.
The activity begins when nerve growth factor binds a receptor capable of transducing its signal. NGF engages two receptors, the TrkA tyrosine kinase and p75NTR, and the two-receptor system allows a single ligand to produce multiple functional outcomes. This binding event is the defining step of GO:0010465, because the term is defined by combining with NGF and converting that binding into a cellular response.
TrkA-mediated survival and growth signaling
In simple terms: One receptor, TrkA, sends a 'stay alive and grow' signal into the cell.
TrkA is the high-affinity NGF receptor that initiates survival and neurite growth signaling. The two-receptor model established that NGF uses TrkA and p75NTR to mediate distinct and sometimes opposing functions. In disease contexts, TrkA signaling has been examined in the brain of streptozotocin-induced type 1 diabetes rats, where NGF receptor signaling changes were reported.
p75NTR-mediated context-dependent signaling
In simple terms: The second receptor, p75NTR, can change the message depending on the cell.
p75NTR (NGFR) is the second NGF receptor and can modulate survival, apoptosis, and cell activation depending on context. Recent work shows that NGFR signaling is not restricted to neurons: it limits inflammation and promotes remodeling and repair of osteoarthritic joints, regulates stromal cell activation in germinal centers, and supports melanoma lymphangiogenesis and metastasis through an NGFR-dependent mechanism. These findings illustrate that the same molecular function can drive very different biological outputs.
Downstream cellular outcomes
In simple terms: Once the signal is inside, the cell decides whether to survive, grow, or change behavior.
The functional output of GO:0010465 is defined as preventing apoptosis in neurons and promoting nerve growth, or initiating a change in cell activity. In cancer, NGFR signaling has been linked to increased tumor growth and metastatic potential in triple-negative breast cancer cells and to glioblastoma progression. In joint biology, NGFR limits inflammation and supports repair. The diversity of outcomes underscores that the activity must be measured in the specific cellular context under study.
Key Genes Involved in GO:0010465 nerve growth factor receptor activity
The genes below encode the receptors, ligands, and signaling components most directly associated with nerve growth factor receptor activity (GO:0010465) and its reported disease roles.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGFR | Encodes p75NTR, the low-affinity NGF receptor | Central to GO:0010465; implicated in osteoarthritis, glioblastoma, melanoma metastasis, germinal centers |
| NTRK1 | Encodes TrkA, the high-affinity NGF receptor tyrosine kinase | Mediates NGF survival and growth signaling; altered in type 1 diabetes brain |
| NGF | Encodes the nerve growth factor ligand | Ligand that defines the binding step of GO:0010465 |
| SORT1 | Encodes sortilin, a co-receptor for p75NTR | Modulates p75NTR-dependent signaling outcomes |
| TP53 | Tumor suppressor frequently co-analyzed with NGFR in cancer models | Context for NGFR-driven tumor phenotypes |
| EGFR | Receptor tyrosine kinase that can cross-talk with NGF receptor signaling | Relevant to glioblastoma and breast cancer models |
| MAPK1 | Downstream kinase in neurotrophin signaling | Readout of NGF receptor pathway activation |
| AKT1 | Survival kinase downstream of TrkA | Measures survival arm of GO:0010465 |
| NFKB1 | Transcription factor linked to p75NTR signaling | Context-dependent inflammatory output |
| JUN | Stress-response transcription factor downstream of p75NTR | Apoptotic arm of NGF receptor signaling |
| TNF | Inflammatory cytokine modulated by NGFR in joint tissue | Osteoarthritis inflammation models |
| IL6 | Inflammatory cytokine relevant to NGFR-dependent inflammation | Joint and stromal cell models |
| CCL19 | Chemokine associated with germinal center stromal activation | NGFR-dependent germinal center biology |
| CCL21 | Chemokine associated with stromal cell activation | Germinal center and lymphoid models |
| VEGFC | Lymphangiogenic factor linked to melanoma extracellular vesicles | NGFR-dependent lymphangiogenesis |
| PECAM1 | Endothelial marker used to assess lymphangiogenesis | Melanoma metastasis models |
| CDH1 | Epithelial marker relevant to breast cancer phenotypes | Triple-negative breast cancer models |
| VIM | Mesenchymal marker relevant to tumor progression | Breast cancer and glioblastoma models |
How Is nerve growth factor receptor activity Regulated?
Nerve growth factor receptor activity is regulated at multiple levels. The balance between TrkA and p75NTR determines whether NGF binding produces survival or apoptotic signaling, as established by the two-receptor model. Co-receptors such as sortilin modulate p75NTR output. In disease contexts, the receptor's effect is further shaped by the tissue environment: NGFR signaling limits inflammation in osteoarthritic joints, regulates stromal cell activation in germinal centers, and is influenced by tumor-derived small extracellular vesicles in melanoma. Because these regulatory inputs are context-specific, experimental models must control for cell type, receptor ratio, and the presence of ligand and co-receptors.
nerve growth factor receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NGFR | Glioblastoma progression | Knockout and overexpression in glioblastoma cell lines |
| NGFR | Melanoma lymphangiogenesis and metastasis | NGFR-dependent extracellular vesicle transfer models |
| NGFR | Osteoarthritis inflammation and repair | Joint tissue and chondrocyte models |
| NGFR | Triple-negative breast cancer growth and metastasis | Knockout and overexpression in TNBC cell lines |
| NTRK1 | Type 1 diabetes brain signaling | Streptozotocin-induced diabetes rat brain models |
Cancer: glioblastoma, melanoma, and breast cancer
NGFR signaling has been identified as a key player in glioblastoma progression. In melanoma, melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. In triple-negative breast cancer cells, NGFR increases tumor growth and metastatic potential. Together these studies show that GO:0010465-associated activity can promote aggressive tumor phenotypes, making the receptor a candidate target for functional studies.
Osteoarthritis and joint remodeling
NGFR limits inflammation and promotes remodeling and repair of osteoarthritic joints. This work expanded the role of NGF receptor activity beyond the nervous system and into musculoskeletal biology, where the receptor appears to restrain inflammatory damage and support tissue repair.
Metabolic and neurological stress: type 1 diabetes
TrkA signaling has been studied in the brain of streptozotocin-induced type 1 diabetes rats, where NGF receptor signaling changes were reported. This links GO:0010465 to neurological complications of metabolic disease.
Immune regulation: germinal centers
NGFR regulates stromal cell activation in germinal centers, indicating that NGF receptor activity participates in the organization of immune responses and lymphoid tissue function.
From nerve growth factor receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NGFR alter tumor growth? | NGFR knockout in cancer cell lines |
| Does a specific NGFR variant change signaling? | Point-mutation knock-in at the endogenous NGFR locus |
| Can a tagged receptor be tracked in live cells? | Tagged knock-in of NGFR or NTRK1 |
| Does overexpression mimic ligand-driven activation? | NGFR or NTRK1 overexpression cell model |
| Which downstream genes respond to NGF receptor activity? | Knockout plus transcriptomic profiling |
| Does NGFR signaling depend on stromal context? | Germinal center stromal cell models |
How to Study the nerve growth factor receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Assigning causality to NGFR/NTRK1 |
| Point mutation knock-in | Effect of specific variants | Dissecting receptor signaling domains |
| Tagged knock-in | Receptor localization and dynamics | Live-cell imaging of NGF receptor |
| Overexpression | Gain-of-function phenotype | Tumor growth and metastasis assays |
| RNA sequencing | Transcriptional response | Downstream pathway discovery |
| Western blot / phospho-assays | Protein activation state | MAPK/AKT pathway readouts |
| In vivo imaging | Tumor and lymphatic dynamics | Melanoma metastasis models |
| Animal disease models | Organism-level phenotype | Type 1 diabetes brain signaling |
CRISPR-based perturbation
CRISPR knockout, point mutation, knock-in, and overexpression are used to isolate the contribution of NGFR and NTRK1 to phenotypes such as tumor growth, metastasis, and joint inflammation.
Transcriptomic and pathway profiling
RNA sequencing and pathway analysis after receptor perturbation reveal downstream programs, as used to study NGFR-dependent stromal activation in germinal centers and inflammation in osteoarthritis.
Protein and signaling assays
Western blotting and phospho-protein assays measure activation of downstream kinases such as MAPK1 and AKT1 following NGF receptor engagement.
Imaging and in vivo models
Imaging of lymphangiogenesis and metastasis in melanoma models has been used to demonstrate NGFR-dependent effects, while animal models of type 1 diabetes have been used to study TrkA signaling in the brain.
How CRISPR Can Be Used to Study GO:0010465 nerve growth factor receptor activity
Knockout
CRISPR knockout of NGFR or NTRK1 removes the receptor and allows researchers to test whether a phenotype depends on nerve growth factor receptor activity. This approach has been used to study tumor growth and metastasis in breast cancer and melanoma models and to examine inflammation in osteoarthritis.
Point Mutation
Point-mutation knock-in introduces specific amino acid changes into the endogenous receptor locus, enabling structure-function analysis of NGF binding and downstream signaling without confounding overexpression artifacts. This is particularly valuable for dissecting the distinct outputs of TrkA and p75NTR.
Knock-in
Tagged knock-in of NGFR or NTRK1 allows the endogenous receptor to be tracked and purified, supporting imaging and interactome studies. This helps define where and when nerve growth factor receptor activity occurs in complex tissues such as germinal centers.
Overexpression
Overexpression models amplify receptor signaling and are used to test sufficiency, for example in triple-negative breast cancer cells where NGFR increases tumor growth and metastatic potential. Overexpression can also reveal ligand-independent effects that require careful interpretation.
How EDITGENE Supports nerve growth factor receptor activity Research
Researchers studying nerve growth factor receptor activity-related genes often need to determine whether a candidate gene is causally involved in a phenotype or merely correlated with it. The most direct way to answer that question is to build isogenic cell models in which the gene of interest is knocked out, mutated, tagged, or overexpressed, and then to measure the downstream signaling and transcriptional consequences. EDITGENE provides these models together with the screening and bioinformatics support needed to interpret them.
Contact EDITGENE today to design your custom CRISPR model for nerve growth factor receptor activity research.
Frequently Asked Questions About nerve growth factor receptor activity
What is GO:0010465 nerve growth factor receptor activity?
It is a Gene Ontology molecular_function term defined as combining with nerve growth factor (NGF) to prevent apoptosis in neurons and promote nerve growth, or to initiate a change in cell activity.
What genes are involved in nerve growth factor receptor activity?
The core genes are NGFR (p75NTR) and NTRK1 (TrkA), together with the ligand NGF and co-receptors such as sortilin.
What is the difference between TrkA and p75NTR?
TrkA is the high-affinity NGF receptor tyrosine kinase, while p75NTR is the low-affinity receptor; the two-receptor system allows NGF to mediate multiple functions.
Is NGFR involved in cancer?
Yes. NGFR has been implicated in glioblastoma progression, melanoma lymphangiogenesis and metastasis, and triple-negative breast cancer growth and metastasis.
Does nerve growth factor receptor activity matter in osteoarthritis?
Yes. NGFR limits inflammation and promotes remodeling and repair of osteoarthritic joints.
How do you study nerve growth factor receptor activity?
Common approaches include CRISPR knockout, point mutation, knock-in, overexpression, RNA sequencing, signaling assays, and in vivo imaging.
What are the synonyms of GO:0010465?
The synonyms are beta-nerve growth factor receptor activity and NGF receptor activity.
Is nerve growth factor receptor activity only in neurons?
No. It has been reported in joint tissue, germinal center stroma, melanoma, breast cancer, and glioblastoma.
What happens when NGF binds its receptor?
Binding initiates signaling that can prevent apoptosis, promote nerve growth, or change cell activity, depending on the receptor and context.
Can CRISPR be used to model GO:0010465-related disease?
Yes. CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to test receptor function in cancer and inflammatory disease.
Conclusion
GO:0010465 nerve growth factor receptor activity is a molecular function that converts NGF binding into neuronal survival, nerve growth, or a change in cell activity, mediated by the TrkA and p75NTR receptors. Once viewed mainly as a neurotrophic function, it is now linked to osteoarthritis, glioblastoma, melanoma metastasis, triple-negative breast cancer, type 1 diabetes brain signaling, and germinal center biology. Because the outcome depends on receptor balance and cellular context, rigorous causal studies require isogenic perturbation models. CRISPR knockout, point-mutation, knock-in, and overexpression approaches, combined with transcriptomic and signaling readouts, provide the experimental framework for dissecting this activity in health and disease.
References
- 1. Zhao L et al.. 2024. Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints.. Nat Commun 15(1):3225 PMID: 38622181
- 2. Kidder BM et al.. 2026. Nerve growth factor receptor (NGFR): A key player in glioblastoma progression.. Biochim Biophys Acta Rev Cancer 1881(4):189645 PMID: 42362096
- 3. García-Silva S et al.. 2021. Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism.. Nat Cancer 2(12):1387-1405 PMID: 34957415
- 4. Zhao L et al.. 2023. Nerve Growth Factor Receptor Limits Inflammation to Promote Remodeling and Repair of Osteoarthritic Joints.. bioRxiv PMID: 38187570
- 5. Wu R et al.. 2021. Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells.. Oncogene 40(12):2165-2181 PMID: 33627781
- 6. Vines K et al.. 2019. Nerve growth factor receptor TrkA signaling in streptozotocin-induced type 1 diabetes rat brain.. Biochem Biophys Res Commun 514(4):1285-1289 PMID: 31113619
- 7. Hernández-Barranco A et al.. 2024. NGFR regulates stromal cell activation in germinal centers.. Cell Rep 43(2):113705 PMID: 38307025
- 8. Frade JM et al.. 1998. Nerve growth factor: two receptors, multiple functions.. Bioessays 20(2):137-45 PMID: 9631659
